NCNA
Price:
$4.43
Market Cap:
$20.16M
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with pancreatic cancer. The company is also developing NUC-3373, a ProTide transformati...[Read more]
Industry
Biotechnology
IPO Date
2017-09-28
Stock Exchange
NASDAQ
Ticker
NCNA
According to NuCana plc’s latest financial reports and current stock price. The company's current ROE is -580.99%. This represents a change of 364.29% compared to the average of -125.13% of the last 4 quarters.
The mean historical ROE of NuCana plc over the last ten years is -79.77%. The current -580.99% ROE has changed 628.29% with respect to the historical average. Over the past ten years (40 quarters), NCNA's ROE was at its highest in in the June 2016 quarter at 0%. The ROE was at its lowest in in the March 2017 quarter at -6485.48%.
Average
-79.77%
Median
-32.31%
Minimum
-319.06%
Maximum
-16.96%
Discovering the peaks and valleys of NuCana plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 123.18%
Maximum Annual ROE = -16.96%
Minimum Annual Increase = -31.36%
Minimum Annual ROE = -319.06%
| Year | ROE | Change |
|---|---|---|
| 2024 | -319.06% | 71.90% |
| 2023 | -185.61% | 123.18% |
| 2022 | -83.17% | 34.49% |
| 2021 | -61.84% | 99.99% |
| 2020 | -30.92% | -8.27% |
| 2019 | -33.71% | 98.73% |
| 2018 | -16.96% | -31.36% |
| 2017 | -24.71% | 3.11% |
| 2016 | -23.96% | 34.66% |
| 2015 | -17.80% | -0.52% |
The current ROE of NuCana plc (NCNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-195.95%
5-year avg
-136.12%
10-year avg
-79.77%
NuCana plc’s ROE is greater than MetaVia Inc. (-212.00%), greater than Lisata Therapeutics, Inc. (-78.18%), greater than Passage Bio, Inc. (-103.87%), greater than Enlivex Therapeutics Ltd. (-62.91%), greater than CytoMed Therapeutics Limited (-54.74%), less than CASI Pharmaceuticals, Inc. (358.32%), greater than Pelthos Therapeutics Inc. (-210.32%), greater than CollPlant Biotechnologies Ltd. (-102.03%), less than NeuroSense Therapeutics Ltd. (2.72%), less than Clearside Biomedical, Inc. (65.87%),
| Company | ROE | Market cap |
|---|---|---|
| -212.00% | $16.10M | |
| -78.18% | $17.90M | |
| -103.87% | $29.19M | |
| -62.91% | $28.19M | |
| -54.74% | $21.71M | |
| 358.32% | $15.16M | |
| -210.32% | $17.09M | |
| -102.03% | $26.70M | |
| 2.72% | $29.60M | |
| 65.87% | $4.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NuCana plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NuCana plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NuCana plc's ROE?
How is the ROE calculated for NuCana plc (NCNA)?
What is the highest ROE for NuCana plc (NCNA)?
What is the 3-year average ROE for NuCana plc (NCNA)?
What is the 5-year average ROE for NuCana plc (NCNA)?
How does the current ROE for NuCana plc (NCNA) compare to its historical average?